SCHEMBL29375720

SCHEMBL29375720

COc1ccc2[nH]cc(CCO)c2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 1.00
HTR2A P28223 5/20 0.73
HTR1A P08908 5/20 0.73
CYP1A2 P05177 3/20 0.73
HTR1D P28221 2/20 0.73
HTR1B P28222 2/20 0.73
HTR2C P28335 2/20 0.73
HTR7 P34969 2/20 0.73
HTR6 P50406 2/20 0.73
HTR4 Q13639 2/20 0.73
MAPT P10636 1/20 0.73
TSHR P16473 1/20 0.73
NFKB1 P19838 1/20 0.73
TRPM8 Q7Z2W7 1/20 0.73
GPR84 Q9NQS5 1/20 0.71
BLM P54132 2/20 0.71
PMP22 Q01453 2/20 0.71
NPSR1 Q6W5P4 1/20 0.71
MTNR1A P48039 4/20 0.69
HTR2B P41595 3/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL676574 1.00 CYP2D6 (1.00) CYP2D6HTR2AHTR1ACYP1A2HTR1D
SCHEMBL8306922 0.91 CYP2D6 (0.83) CYP2D6HTR2AHTR1ACYP1A2HTR1D
SCHEMBL9329211 0.90 CYP2D6 (0.81) CYP2D6HTR2AHTR1ACYP1A2HTR1D
SCHEMBL5362738 0.88 CYP2D6 (0.79) CYP2D6HTR2AHTR1ACYP1A2HTR1D
SCHEMBL5368511 0.88 CYP2D6 (0.79) CYP2D6HTR2AHTR1ACYP1A2HTR1D
SCHEMBL5363947 0.88 CYP2D6 (0.79) CYP2D6HTR2AHTR1ACYP1A2HTR1D
SCHEMBL5360884 0.88 CYP2D6 (0.79) CYP2D6HTR2AHTR1ACYP1A2HTR1D
SCHEMBL5350306 0.88 CYP2D6 (0.79) CYP2D6HTR2AHTR1ACYP1A2HTR1D
SCHEMBL29899096 0.88 CYP2D6 (0.78) CYP2D6HTR2AHTR1ACYP1A2HTR1D
SCHEMBL3812224 0.88 CYP2D6 (0.78) CYP2D6HTR2AHTR1ACYP1A2HTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4658371-A1 5-MEO-DMT FOR USE IN THE TREATMENT OF POSTPARTUM DEPRESSION GH Research Ireland Limited (IE) 2025-12-10 EP disclosed
EP-4658267-A1 TREATMENT OF MENTAL DISORDERS GH Research Ireland Limited (IE) 2025-12-10 EP disclosed
EP-4658266-A1 5-METHOXY-N,N-DIMETHYLTRYPTAMINE FOR USE IN THE TREATMENT OF MENTAL DISORDERS IN BREASTFEEDING MOTHERS GH Research Ireland Limited (IE) 2025-12-10 EP disclosed
EP-4499086-A1 TREATMENT OF MENTAL DISORDERS GH Research Ireland Limited (IE) 2025-02-05 EP disclosed
EP-4499089-A1 TREATMENT OF POSTNATAL DEPRESSION GH Research Ireland Limited (IE) 2025-02-05 EP disclosed
EP-4499079-A1 5-MEO-DMT FOR USE IN THE TREATMENT OF POSTPARTUM DEPRESSION GH Research Ireland Limited (IE) 2025-02-05 EP disclosed
WO-2024160391-A1 TREATMENT OF MENTAL DISORDERS GH Research Ireland Limited (IE) 2024-08-08 WO disclosed
WO-2024160389-A1 5-METHOXY-N,N-DIMETHYLTRYPTAMINE FOR USE IN THE TREATMENT OF MENTAL DISORDERS IN BREASTFEEDING MOTHERS GH Research Ireland Limited (IE) 2024-08-08 WO disclosed
WO-2024160392-A1 5-MEO-DMT FOR USE IN THE TREATMENT OF POSTPARTUM DEPRESSION GH Research Ireland Limited (IE) 2024-08-08 WO disclosed
WO-2023186826-A1 5-MEO-DMT FOR USE IN THE TREATMENT OF POSTPARTUM DEPRESSION GH Research Ireland Limited (IE) 2023-10-05 WO disclosed
WO-2023186835-A1 TREATMENT OF MENTAL DISORDERS GH Research Ireland Limited (IE) 2023-10-05 WO disclosed
WO-2023186837-A1 TREATMENT OF POSTNATAL DEPRESSION GH Research Ireland Limited (IE) 2023-10-05 WO disclosed
WO-2023023298-A1 HALLUCINOGENIC AND NON-HALLUCINOGENIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME PSILOSTERICS, LLC (US) 2023-02-23 WO disclosed
EP-4003395-A1 COMPOSITIONS CONTAINING TOAD SECRETION COMPOUNDS Caamtech, Inc. (US) 2022-06-01 EP disclosed